Atezolizumab and bevacizumab in hepatocellular carcinoma

David Bomze, Tomer Meirson, Daniel Azoulay

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Original language	English
Pages (from-to)	693-694
Number of pages	2
Journal	New England Journal of Medicine
Volume	383
Issue number	7
State	Published - 13 Aug 2020

Cite this

@article{a0d11a7b9cce44e0a0419683b7c269d8,

title = "Atezolizumab and bevacizumab in hepatocellular carcinoma",

author = "David Bomze and Tomer Meirson and Daniel Azoulay",

year = "2020",

month = aug,

day = "13",

language = "אנגלית",

volume = "383",

pages = "693--694",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "7",

}

TY - JOUR

T1 - Atezolizumab and bevacizumab in hepatocellular carcinoma

AU - Bomze, David

AU - Meirson, Tomer

AU - Azoulay, Daniel

PY - 2020/8/13

Y1 - 2020/8/13

UR - http://www.scopus.com/inward/record.url?scp=85089408128&partnerID=8YFLogxK

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 32786198

AN - SCOPUS:85089408128

SN - 0028-4793

VL - 383

SP - 693

EP - 694

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 7

ER -